Opinion: China’s Covid-19 mRNA Vaccine Challenge

As the omicron variant of Covid-19 sweeps across China in the latest wave of the pandemic, the development of homegrown vaccines again stepped into the spotlight.

Since March, a rising tide of virus flare-ups has forced a number of Chinese cities into lockdown, including the Asian financial hub Shanghai. As China fights its worst outbreak since Wuhan, progress by domestic drugmakers in the development of Covid-19 vaccines based on the advanced mRNA technology made headlines.